Abstract
Cytotoxic lymphocyte maturation factor (CLMF) is a disulfide-bonded heterodimeric lymphokine that (i) acts as a growth factor for activated T cells independent of interleukin 2 and (ii) synergizes with suboptimal concentrations of interleukin 2 to induce lymphokine-activated killer cells. We now report the cloning and expression of both human CLMF subunit cDNAs from a lymphoblastoid B-cell line, NC-37. The two subunits represent two distinct and unrelated gene products whose mRNAs are coordinately induced upon activation of NC-37 cells. Coexpression of the two subunit cDNAs in COS cells is necessary for the secretion of biologically active CLMF; COS cells transfected with either subunit cDNA alone do not secrete bioactive CLMF. Recombinant CLMF expressed in mammalian cells displays biologic activities essentially identical to natural CLMF, and its activities can be neutralized by monoclonal antibodies prepared against natural CLMF. Since this heterodimeric protein displays the properties of an interleukin, we propose that CLMF be given the designation interleukin 12.
MeSH Terms
Amino Acid Sequence
B-Lymphocytes/chemistry
Base Sequence
Cell Line
Cloning, Molecular
DNA/genetics
Gene Expression
Humans
Interleukin-12
Interleukins/chemistry,genetics,pharmacology
Molecular Sequence Data
RNA, Messenger/genetics
Recombinant Proteins/pharmacology
Transfection
Chemicals
Interleukins
RNA, Messenger
Recombinant Proteins
Interleukin-12
DNA
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Gubler U
Department of Molecular Genetics, Roche Research Center, Hoffmann-La Roche, Inc., Nutley, NJ 07110.
Chua A O
Schoenhaut D S
Dwyer C M
McComas W
Motyka R
Nabavi N
Wolitzky A G
Quinn P M
Familletti P C
References (15)
15 references, click to expand
-
A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.
Cell. 1986 Aug 29;46(5):659-67
PMID: 3488815
-
Establishing homologies in protein sequences.
Methods Enzymol. 1983;91:524-45
PMID: 6855599
-
Interleukin secretion by B cell lines and splenic B cells stimulated with calcium ionophore and phorbol ester.
J Immunol. 1987 Nov 1;139(9):2957-64
PMID: 3117882
-
In vivo antitumor activity of multiple injections of recombinant interleukin 2, alone and in combination with three different types of recombinant interferon, on various syngeneic murine tumors.
Cancer Res. 1988 Jan 15;48(2):260-4
PMID: 2446744
-
Gonadotropin beta subunits determine the rate of assembly and the oligosaccharide processing of hormone dimer in transfected cells.
J Cell Biol. 1987 May;104(5):1173-81
PMID: 2437127
-
Synergy between recombinant interleukin 2 (rIL 2) and IL 2-depleted lymphokine-containing supernatants in facilitating allogeneic human cytolytic T lymphocyte responses in vitro.
J Immunol. 1986 Feb 15;136(4):1274-82
PMID: 2418110
-
Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.
J Exp Med. 1989 Sep 1;170(3):827-45
PMID: 2504877
-
Characterization of a factor(s) which synergizes with recombinant interleukin 2 in promoting allogeneic human cytolytic T-lymphocyte responses in vitro.
Cell Immunol. 1988 Jan;111(1):39-54
PMID: 3276403
-
Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models.
Cancer Res. 1987 Aug 1;47(15):3948-53
PMID: 3496953
-
Use of eukaryotic expression technology in the functional analysis of cloned genes.
Methods Enzymol. 1987;152:684-704
PMID: 3657593
-
Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.
N Engl J Med. 1985 Dec 5;313(23):1485-92
PMID: 3903508
-
Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.
J Exp Med. 1985 May 1;161(5):1169-88
PMID: 3886826
-
Interleukin 2 production by a marmoset B cell line.
Eur J Immunol. 1990 May;20(5):1125-9
PMID: 2162776
-
Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells.
Proc Natl Acad Sci U S A. 1990 Sep;87(17):6808-12
PMID: 2204066
-
Activated B cells can deliver help for the in vitro generation of antiviral cytotoxic T cells.
Proc Natl Acad Sci U S A. 1989 Jun;86(12):4629-33
PMID: 2786634